PHILADELPHIA - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has introduced its new slate of officers for 2018-2019.
Dr. Satoshi Minoshima, PhD, 2018-2019 president of SNMMI.
In addition, he said the society will strategize future training pathways and promote members' leadership in the imaging and healthcare fields, as well as continue its outreach efforts to patients, referral communities, and other stakeholders. The SNMMI will also promote diversity in workflow and leadership, he said.
The SNMMI has also named Dr. Vasken Dilsizian as president-elect. A professor of radiology and medicine at the University of Maryland School of Medicine and chief of nuclear medicine at the University of Maryland Medical Center, Dilsizian said his goals for 2018-2019 include cultivating opportunities for collaboration with other professional organizations, underscoring the value of molecular imaging for patient management, promoting additional subspecialty nuclear medicine training, and fostering scientific investigations.
"The clinical translation of new diagnostic and therapeutic radiopharmaceuticals and their integration into patient management and appropriate use guidelines is the very vital lifeline of our organization," he said in a statement. "Such developments would ensure the SNMMI's survival in the new millennium."
Dilsizian said he will also pursue partnerships with other international organizations and work to increase international membership.
The society has also appointed Alan Packard, PhD, as vice president-elect. Packard is currently an associate professor of radiology at Harvard Medical School, director of radiopharmaceutical research and a senior research associate in nuclear medicine at Boston Children's Hospital, and a research associate in nuclear medicine at Brigham and Women's Hospital.
